Login / Signup
Megha Kaushal
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Clinical Trial
Multiple Myeloma
Monoclonal Antibody
Ejection Fraction
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Kavita Natrajan
,
Megha Kaushal
,
Bindu George
,
Bindu Kanapuru
,
Marc R Theoret
FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (14) (2024)
Kavita Natrajan
,
Megha Kaushal
,
Bindu George
,
Bindu Kanapuru
,
Marc R Theoret
FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (14) (2024)
Kavita Natrajan
,
Megha Kaushal
,
Bindu George
,
Bindu Kanapuru
,
Marc R Theoret
FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)